Form 4 for ABT Abbott Laboratories
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001415889-25-006786 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | 2025-03-03 | ABT | Moreland Mary K | EVP | S - Sale | $138.17 | -791 | 95.6K | -0.8% | -$109.3K | |
| 2025-03-04 | 2025-02-28 | ABT | Moreland Mary K | EVP | F - Tax | $135.87 | -5,598 | 96.4K | -5% | -$760.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2025-03-03 | S | D | 791 | $138.17 | 95,583 | D | — | — | |
| 2 | Common | Common shares without par value | 2025-02-28 | F | D | 5,598 | $135.87 | 96,374 | D | — | — |